Why Sarepta’s Gene Therapy Trial Enrollment Has Been More Successful Than Its Other DMD Therapies

 
• By Derrick Gingery
Duchenne muscular dystrophy
DMD advocates hope Sarepta's gene therapy candidate can push development in the disease forward. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies